Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle Emitter
- 30 April 1998
- journal article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 25 (3), 241-246
- https://doi.org/10.1016/s0969-8051(97)00200-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Vascular Targeting for Radioimmunotherapy with 213BiRadiochimica Acta, 1997
- Optimizations of Radiolabeling of Immunoproteins with 213BiRadiochimica Acta, 1997
- Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor VasculatureScience, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Characterization of organ-specific immunoliposomes for delivery of 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine in a mouse lung-metastasis modelCancer Chemotherapy and Pharmacology, 1995
- Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470Journal of Pediatric Surgery, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labelling of monoclonal antibodies with the bismuth-212 α-particle emitterJournal of the Chemical Society, Perkin Transactions 1, 1992
- Selection of Successive Tumour Lines for MetastasisNature New Biology, 1973